ATX-101 for the reduction of double chin caused by submental fat: Results from the ATX-101-10-16 European phase III study

doi:10.1016/j.jaad.2012.12.093

ATX-101 for the reduction of double chin caused by submental fat: Results from the ATX-101-10-16 European phase III study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2012.12.093 ◽

2013 ◽

Vol 68 (4) ◽

pp. AB22

Keyword(s):

Phase Iii ◽

Phase Iii Study ◽

Double Chin ◽

Submental Fat

Download Full-text

Reduction of double chin caused by submental fat with ATX-101: Results from the ATX-101-10-17 European phase III study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2012.12.107 ◽

2013 ◽

Vol 68 (4) ◽

pp. AB25

Keyword(s):

Phase Iii ◽

Phase Iii Study ◽

Double Chin ◽

Submental Fat

Download Full-text

Phase III Study Makes Case for IV Chemoradiation

Skin & Allergy News ◽

10.1016/s0037-6337(06)71820-4 ◽

2007 ◽

Vol 38 (1) ◽

pp. 46-47

Author(s):

BRUCE WILSON

Keyword(s):

Phase Iii ◽

Phase Iii Study

Download Full-text

Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non–Small-Cell Lung Cancer

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70422-6 ◽

2007 ◽

Vol 2007 ◽

pp. 206-207

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Oral Topotecan

Download Full-text

Rationale for a phase III study of erythropoietin as a neurocognitive protectant in patients with lung cancer receiving prophylactic cranial irradiation

Seminars in Oncology ◽

10.1053/sonc.2002.37362 ◽

2002 ◽

Vol 29 (6 Suppl 19) ◽

pp. 47-52 ◽

Cited By ~ 38

Author(s):

Neil Senzer

Keyword(s):

Lung Cancer ◽

Cranial Irradiation ◽

Prophylactic Cranial Irradiation ◽

Phase Iii ◽

Phase Iii Study

Download Full-text

Treatment of Genotype 1 HCV Treatment-Naïve Patients: final results of phase III study ADVANCE

Zeitschrift für Gastroenterologie ◽

10.1055/s-0030-1269659 ◽

2011 ◽

Vol 49 (01) ◽

Author(s):

T Berg ◽

P Buggisch ◽

P Malinski ◽

H Diepolder ◽

S Mauss ◽

...

Keyword(s):

Phase Iii ◽

Genotype 1 ◽

Hcv Treatment ◽

Treatment Naïve ◽

Phase Iii Study

Download Full-text

Randomized controlled phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer – AGO DESKTOP III/ENGOT ov20

10.1055/s-0038-1671029 ◽

2018 ◽

Author(s):

P Harter ◽

J Sehouli ◽

W Meier ◽

A Reuss ◽

P Hillemanns ◽

...

Keyword(s):

Ovarian Cancer ◽

Cytoreductive Surgery ◽

Recurrent Ovarian Cancer ◽

Phase Iii ◽

Randomized Controlled ◽

Secondary Cytoreductive Surgery ◽

Phase Iii Study ◽

The Impact

Download Full-text

Phase III study of vinflunine versus docetaxel in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a platinum-containig regimen

Pneumologie ◽

10.1055/s-2008-1074239 ◽

2008 ◽

Vol 62 (S 2) ◽

Author(s):

J von Pawel ◽

M Reck ◽

R Ramlau ◽

J Jassem ◽

P Zatloukal ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Previously Treated

Download Full-text

Pharmacokinetic (PK) and pharmacodynamic (PD) analyses of pasireotide LAR and octreotide LAR: Randomized, double-blind Phase III study in patients with medically naive acromegaly

Endocrine Abstracts ◽

10.1530/endoabs.35.p918 ◽

2014 ◽

Cited By ~ 2

Author(s):

George Shen ◽

Christelle Darstein ◽

Karina Hermosillo Resendiz ◽

Yanfeng Wang ◽

Ke Hu

Keyword(s):

Phase Iii ◽

Double Blind ◽

Octreotide Lar ◽

Phase Iii Study

Download Full-text

Multicenter, Randomized Phase III Study of Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for the Treatment of Uterine Fibroids (MRgFUS TUF) Compared to Myomectomy in Symptomatic Medication and Not Sufficiently Treatable Uterine Fibroids

Case Medical Research ◽

10.31525/ct1-nct03948789 ◽

2019 ◽

Author(s):

Keyword(s):

Magnetic Resonance ◽

Focused Ultrasound ◽

Uterine Fibroids ◽

Phase Iii ◽

Ultrasound Surgery ◽

Focused Ultrasound Surgery ◽

Symptomatic Medication ◽

Phase Iii Study

Download Full-text

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Case Medical Research ◽

10.31525/ct1-nct04033354 ◽

2019 ◽

Author(s):

Keyword(s):

Stage Iiib ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text